BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 17242824)

  • 1. Southern Africa is moving swiftly to combat the threat of XDR-TB.
    Wise J
    Bull World Health Organ; 2006 Dec; 84(12):924-5. PubMed ID: 17242824
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination.
    Koenig R
    Science; 2008 Feb; 319(5865):894-7. PubMed ID: 18276863
    [No Abstract]   [Full Text] [Related]  

  • 3. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV/AIDS epidemic poses serious threat to tuberculosis eradication.
    AIDS Policy Law; 2003 Apr; 18(7):4. PubMed ID: 12728846
    [No Abstract]   [Full Text] [Related]  

  • 5. Infectious disease. Extensively drug-resistant TB gets foothold in South Africa.
    Cohen J
    Science; 2006 Sep; 313(5793):1554. PubMed ID: 16973846
    [No Abstract]   [Full Text] [Related]  

  • 6. The TB pandemic: an old problem seeking new solutions.
    Meya DB; McAdam KP
    J Intern Med; 2007 Apr; 261(4):309-29. PubMed ID: 17391107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XDR-TB or not XDR-TB? That is the question.
    Bateman C
    S Afr Med J; 2007 May; 97(5):318, 320, 322. PubMed ID: 17599208
    [No Abstract]   [Full Text] [Related]  

  • 8. TB and HIV: joint problems, joint solutions?
    Elzinga G; Nunn P
    Bull World Health Organ; 2002; 80(6):469-70. PubMed ID: 12132004
    [No Abstract]   [Full Text] [Related]  

  • 9. [Extremely resistant tuberculosis in Africa. The Danish Society for Tropical Medicine and International Health].
    Ravn P; Vestergaard LS; David KP;
    Ugeskr Laeger; 2007 Mar; 169(12):1135. PubMed ID: 17394846
    [No Abstract]   [Full Text] [Related]  

  • 10. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. World Health Organization fact sheet. Tuberculosis.
    World Health Organization
    Saudi Med J; 2004 Aug; 25(8):1136-8. PubMed ID: 15457607
    [No Abstract]   [Full Text] [Related]  

  • 12. Extensively drug-resistant (XDR) tuberculosis: an old and new threat.
    Fattorini L; Migliori GB; Cassone A
    Ann Ist Super Sanita; 2007; 43(4):317-9. PubMed ID: 18209265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa.
    Andrews JR; Gandhi NR; Moodley P; Shah NS; Bohlken L; Moll AP; Pillay M; Friedland G; Sturm AW;
    J Infect Dis; 2008 Dec; 198(11):1582-9. PubMed ID: 18847372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa.
    Mlambo CK; Warren RM; Poswa X; Victor TC; Duse AG; Marais E
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):99-104. PubMed ID: 18173885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tuberculosis in Poland, Europe, and world. Part II--mortality, drug resistance and HIV infection].
    Zielonka TM
    Pol Merkur Lekarski; 2006 Sep; 21(123):253-61. PubMed ID: 17163187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Shortened, strictly supervised tuberculosis treatment in populations with moderate drug resistance levels: international impact perspective].
    Santos-Preciado JI; Franco-Paredes C
    Rev Invest Clin; 2005; 57(3):488-90. PubMed ID: 16187710
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune reconstitution syndrome following initiation of antiretroviral therapy in a patient with HIV infection and multidrug-resistant tuberculosis.
    Swaminathan S; Padmapriyadarsini C; Narendran G; Thomas BE; Anand S; Rajyalakshmi A
    Indian J Chest Dis Allied Sci; 2005; 47(4):299-304. PubMed ID: 16255403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area.
    Schreiber YS; Herrera AF; Wilson D; Wallengren K; Draper R; Muller J; Dawood H; Doucette S; Cameron DW; Alvarez GG
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1274-80. PubMed ID: 19793433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of extensively drug-resistant tuberculosis and role of the pharmacist.
    Mitrzyk BM
    Pharmacotherapy; 2008 Oct; 28(10):1243-54. PubMed ID: 18823220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis and management of HIV/TB co-infection in Asia.
    Goldfeld A; Ellner JJ
    Tuberculosis (Edinb); 2007 Aug; 87 Suppl 1():S26-30. PubMed ID: 17606407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.